Publications Database

Roberts W. et al. (2001)

Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial.

Pediatrics

107(5), e. 71

Read Abstract (New Window) Read Full (New Window)

Robinson G. , Foreman P. (1999)

Scotopic sensitivity/Irlen syndrome and the use of coloured filters: A long-term placebo controlled and masked study of reading achievement and perception of ability.

Perceptual and Motor Skills

89(1), pp. 83-113

Read Abstract (New Window)

Ross D. L. , Klykylo W. M. , Hitzemann R. (1987)

Reduction of elevated CSF beta-endorphin by fenfluramine in infantile autism.

Pediatric Neurology

3(2), pp. 83-86

Read Abstract (New Window)

Saad K. et al.

Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder.

Journal of Child Psychology and Psychiatry

Read Abstract (New Window)

Sanchez L. e. et al. (1995)

A comparison of live and videotape ratings: clomipramine and haloperidol in autism.

Psychopharmacology Bulletin

31(2), pp. 371-378.

Read Abstract (New Window)

Sandler A. D. et al. (1999)

Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.

New England Journal of Medicine

341(24), pp. 1801-1806

Read Abstract (New Window) Read Full (New Window)

Scahill L. et al. (2001)

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

Journal of Child and Adolescent Psychopharmacology

11(4), pp. 377-388

Read Abstract (New Window)

Scahill L. et al. (2017)

Using a patient-centered outcome measure to test methylphenidate versus placebo in children with autism spectrum disorder.

Journal of Child and Adolescent Psychopharmacology

March, 27(2), pp. 125-131.

Read Abstract (New Window) Read Full (New Window)

Scifo R. et al. (1996)

Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone.

Annali dell'Istituto Superiore di Sanita

32(3), pp. 351-359

Read Abstract (New Window)

Shea S. et al. (2004)

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Pediatrics

114(5), e. 634-641

Read Abstract (New Window) Read Full (New Window)

Sheppard K. et al.

Effect of omega-3 and -6 supplementation on language in preterm toddlers exhibiting autism spectrum disorder symptoms.

Journal of Autism and Developmental Disorders

Read Abstract (New Window)

Simonoff E. et al. (2013)

Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.

Journal of Child Psychology and Psychiatry

54(5), pp. 527-535.

Read Abstract (New Window)

Singh K. et al. (2014)

Sulforaphane treatment of autism spectrum disorder (ASD).

Proceedings of the National Academy of Science U S A

111(43), pp. 15550-15555.

Read Abstract (New Window) Read Full (New Window)

Spencer E. K. , Alpert M. , Pouget E. (1994)

Scales for the assessment of neuroleptic response in schizophrenic children: specific measures derived from the CPRS.

Psychosomatic Medicine

30(2), pp. 199-202

Read Abstract (New Window)

Sponheim E. , Oftedal G. , Helverschou S. B. (2002)

Multiple doses of secretin in the treatment of autism: a controlled study.

Acta Paediatrica

91(5), pp. 540-545.

Read Abstract (New Window)

Steiner H. , Kertész Z. (2015)

Effects of therapeutic horse riding on gait cycle parameters and some aspects of behavior of children with autism.

Acta

September, 102(3), pp. 324-335.

Read Abstract (New Window)

Sugie Y. et al. (2005)

Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.

Journal of Autism and Developmental Disorders

35(3), pp. 377-385

Read Abstract (New Window)

Tolbert L. et al. (1993)

Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium.

Journal of Autism and Developmental Disorders

23(1), pp. 193-199

Read Abstract (New Window)

Troost P. et al. (2005)

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.

Journal of the American Academy of Child and Adolescent Psychiatry

44(11), pp. 1137-1144

Read Abstract (New Window)

Umbricht D. et al. (2016)

A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (RG7713) in high-functioning adults with autism spectrum disorder.

Neuropsychopharmacology

Read Abstract (New Window)